Dual diagnosis clients' treatment satisfaction - a systematic review

BMC Psychiatry

John Stirling²  Petra S Meier¹  Sabrina J Schulte³ 

[1] School of Health and Related Research, University of Sheffield, 30 Regent Street, Sheffield, UK;Department of Psychology, Elizabeth Gaskell Campus, Manchester Metropolitan University, Manchester, UK;International Studies Department, American University of Sharjah, P.O. Box: 26666, Sharjah, United Arab Emirates

关键词: substance misuse;    satisfaction;    mental illness;    integrated treatment;    co-morbidity;    Dual diagnosis;   

Others  :  1124572
DOI  :  10.1186/1471-244X-11-64

 received in 2010-12-16, accepted in 2011-04-18,  发布年份 2011

【 摘 要 】

Background

The aim of this systematic review is to synthesize existing evidence about treatment satisfaction among clients with substance misuse and mental health co-morbidity (dual diagnoses, DD).

Methods

We examined satisfaction with treatment received, variations in satisfaction levels by type of treatment intervention and by diagnosis (i.e. DD clients vs. single diagnosis clients), and the influence of factors other than treatment type on satisfaction. Peer-reviewed studies published in English since 1970 were identified by searching electronic databases using pre-defined search strings.

Results

Across the 27 studies that met inclusion criteria, high average satisfaction scores were found. In most studies, integrated DD treatment yielded greater client satisfaction than standard treatment without explicit DD focus. In standard treatment without DD focus, DD clients tended to be less satisfied than single diagnosis clients. Whilst the evidence base on client and treatment variables related to satisfaction is small, it suggested client demographics and symptom severity to be unrelated to treatment satisfaction. However, satisfaction tended to be linked to other treatment process and outcome variables. Findings are limited in that many studies had very small sample sizes, did not use validated satisfaction instruments and may not have controlled for potential confounders. A framework for further research in this important area is discussed.

Conclusions

High satisfaction levels with current treatment provision, especially among those in integrated treatment, should enhance therapeutic optimism among practitioners dealing with DD clients.

【 授权许可】

   
2011 Schulte et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Mangrum LF, Spence RT, Lopez M: Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders. J Subst Abuse Treat 2006, 30:79-84.
• [2]Drake RE, McHugo GJ, Clark RE, Teague GB, Xie H, Miles K: Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: a clinical trial. Am J Orthopsychiat 1998, 68:201-215.
• [3]Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto J, Hennen A: Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. J Clin Psychiatr 2000, 61:361-367.
• [4]Tiet QQ, Mausbach B: Treatments for Patients With Dual Diagnosis: A Review. Alcohol Clin Exp Res 2007, 31:513-536.
• [5]Donald M, Dower J, Kavanagh D: Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Soc Sci Med 2005, 60:1371-1383.
• [6]Cleary M, Hunt G, Matheson S, Siegfried N, Walter G: Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews 2008.
• [7]Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR: Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders. Schizophr Bull 1998, 24:589-608.
• [8]Drake RE, Mueser KT, Brunette MF, McHugo GJ: A review of treatments for people with severe mental illness and co-occurring substance use disorder. Psychiatr Rehabil J 2004, 27:360-374.
• [9]Drake RE, O'Neal EL, Wallach MA: A systematic review of psychosocial research on psychosocial interventions for people with co-occurring severe mental and substance use disorders. J Subst Abuse Treat 2008, 34:123-138.
• [10]Hesse M: Integrated psychological treatment for substance use and co-morbid anxiety or depression vs. treatment for substance use alone. A systematic review of the published literature. BMC Psychiatry 2009, 9:6. BioMed Central Full Text
• [11]Marsden J, Stewart D, Gossop M, Rolfe A, Bacchus L, Griffiths P, Clarke K, Strang J: Assessing Client Satisfaction with Treatment for Substance Use Problems and the Development of the Treatment Perceptions Questionnaire (TPQ). Addict Res Theory 2000, 8:455-470.
• [12]Carlson MJ, Gabriel RM: Patient Satisfaction, Use of Services, and One-Year Outcomes in Publicly Funded Substance Abuse Treatment. Psychiatr Serv 2001, 52:1230-1236.
• [13]Herman JS, Jan JK, van Crétien C, Loe P: Quality of care from the patients' perspective: from theoretical concept to a new measuring instrument. Health Expect 1998, 1:82-95.
• [14]Adams JR, Drake RE: Shared Decision-Making and Evidence-Based Practice. Community Ment Health J 2006, 42:87-105.
• [15]Hansson L, Bjoerkman T, Priebe S: Are important patient-rated outcomes in community mental health care explained by only one factor? Acta Psychiatr Scand 2007, 116:113-118.
• [16]Morris ZS, McKeganey N: Client perceptions of drug treatment services in Scotland. Drugs: Educ Prev Policy 2007, 14:49-60.
• [17]Draper M, Cohen P, Buchan H: Seeking consumer views: what use are results of hospital patient satisfaction surveys? Int J Qual Health Care 2001, 13:463-468.
• [18]Robbins MS, Liddle HA, Turner CW, Dakof GA, Alexander JF, Kogan SM: Adolescent and parent therapeutic alliances as predictors of dropout in multidimensional family therapy. J Fam Psychol 2006, 20:108-116.
• [19]Morris ZS, Gannon M: Drug misuse treatment services in Scotland: predicting outcomes. Int J Qual Health Care 2008, 20:271-276.
• [20]Institute of Medicine: Improving the quality of health care for mental and substance use conditions. Washington, DC: National Academies Press; 2006.
• [21]Howard PB, Rayens MK, El-Mallakh P, Clark JJ: Predictors of Satisfaction Among Adult Recipients of Medicaid Mental Health Services. Arch Psychiatr Nurs 2007, 21:257-269.
• [22]Trujillo M: Implementation of outcome assessment in systems of mental health care. In Outcome measurement in psychiatry: A critical review. Edited by IsHak WW, Burt T, Sederer LI. Washington, DC: American Psychiatric Publishing; 2002:323-345.
• [23]Bjoerk T, Bjoerck C, Clinton D, Sohlberg S, Norring C: What Happened to the Ones Who Dropped Out? Outcome in Eating Disorder Patients Who Complete or Prematurely Terminate Treatment. Eur Eat Disord Rev 2009, 17:109-119.
• [24]World Health Organization: Mental Health Policy, Plans and Programmes. Geneva: World Health Organization; 2004.
• [25]Audit Commission: Drug Misuse 2004: Reducing the Local Impact. London: Audit Commission; 2004.
• [26]National Treatment Agency: Retaining clients in drug treatment. A guide for providers and comissioners. London: National Treatment Agency for Substance Misuse; 2005.
• [27]Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2009]. [http://www.cochrane-handbook.org] webciteThe Cochrane Collaboration; 2009.
• [28]Afuwape SA, Johnson S, Craig TJK, Miles H, Leese M, Mohan R, Thornicroft G: Ethnic differences among a community cohort of individuals with dual diagnosis in South London. JMH 2006, 15:551-567.
• [29]Miles H, Johnson S, Amponsah-Afuwape S, Finch E, Leese M, Thornicroft G: Characteristics of Subgroups of Individuals With Psychotic Illness and a Comorbid Substance Use Disorder. Psychiatr Serv 2003, 54:554-561.
• [30]Morse GA, Calsyn RJ, Dean W, Helminiak TW, Wolff N, Drake RE, Yonker RD, Lama G, Lemming MR, McCudden S: Treating Homeless Clients with Severe Mental Illness and Substance Use Disorders: Costs and Outcomes. Community Ment Health J 2006, 42:377-404.
• [31]Morse GA, Calsyn RJ, Klinkenberg WD, Cunningham J, Lemming MR: Integrated Treatment for Homeless Clients With Dual Disorders: A Quasi-Experimental Evaluation. J Dual Diagn 2008, 4:219-237.
• [32]Primm AB, Gomez MB, Tzolova-Iontchev I, Perry W, Vu HT, Crum RM: Severely Mentally Ill Patients with and Without Substance Use Disorders: Characteristics Associated with Treatment Attrition. Community Ment Health J 2000, 36:235-246.
• [33]Burns L, Teesson M, O'Neill K: The impact of comorbid anxiety and depression on alcohol treatment outcomes. Addiction 2005, 100:787-796.
• [34]Prince JD: Family Involvement and Satisfaction with Community Mental Health Care of Individuals with Schizophrenia. Community Ment Health J 2005, 41:419-430.
• [35]Herrell JM, Fenton W, Mosher LR, Hedlund S, Lee B: Residential Alternatives to Hospitalization for Patients with Severe and Persistent Mental Illness: Should Patiens with Comorbid Substance Abuse be Excluded? J Ment Health Adm 1996, 23:348-355.
• [36]Boden MT, Moos R: Dually diagnosed patients' responses to substance use disorder treatment. J Subst Abuse Treat 2009, 37:335-345.
• [37]Anderson AJ: A Comparative Impact Evaluation of Two Therapeutic Programs for Mentally Ill Chemical Abusers. Int J Psychosoc Rehabil 1999, 4:11-26.
• [38]Aguilera R, Anderson AJ, Gabrie E, Merlo M, Paredes T, Pastrana R: A Clinical Impact Evaluation of Integrated and Disease Specific Substance Abuse Program Models in Honduras. Int J Psychosoc Rehabil 1999, 3:97-167.
• [39]Miles H, Dutheil L, Welsby I, Haider D: 'Just Say No': A preliminary evaluation of a three-stage model of integrated treatment for substance use problems in conditions of medium security. J Psychiatr Psychol 2007, 18:141-159.
• [40]Najavits LM, Weiss RD, Shaw SR, Muenz LR: "Seeking Safety": Outcome of a New Cognitive-Behavioral Psychotherapy for Women with Posttraumatic Stress Disorder and Substance Dependence. J Traum Stress 1998, 11:437-456.
• [41]Clark C, Young MS, Jackson E, Graeber C, Mazelis R, Kammerer N, Huntington N: Consumer Perceptions of Integrated Trauma-Informed Services Among Women with Co-Occurring Disorders. J Behav Health Serv Res 2008, 35:71-90.
• [42]Covington SS, Burke C, S K, C N: Evaluation of a Trauma-Informed and Gender-Responsive Intervention for Women in Drug Treatment. J Psychoactive Drugs 2008, S5:387-398.
• [43]Brown VB, Najavits LM, Cadiz S, Finkelstein N, Heckman JP, Rechberger E: Implementing an Evidence-Based Practice: Seeking Safety Group. J Psychoactive Drugs 2007, 39:231-240.
• [44]Daughters SB, Braun AR, Sargeant MR, Reynolds EK, Hopko DR, Blanco C, Lejuez CW: Effectiveness of a Brief Behavioral Treatment for Inner-City Illicit Drug Users with Elevated Depressive Symptoms: The Life Enhancement Treatment for Substance Use (LETS Act!). J Clin Psychiatr 2008, 69:122-129.
• [45]Shaner A, Eckman T, Roberts LJ, Fuller T: Feasibility of a Skills Training Approach to Reduce Substance Dependence Among Individuals With Schizophrenia. Psychiatr Serv 2003, 54:1287-1289.
• [46]Ries RK, Jaffe C, Comtois KA, Kitchell M: Addiction Services: Treatment Satisfaction Compared with Outcome in Severe Dual Disorders. Community Ment Health J 1999, 35:213-221.
• [47]Godley SH, Finch M, Dougan L, McDonnell M, McDermeit M, Carey A: Case management for dually diagnosed individuals involved in the criminal justice system. J Subst Abuse Treat 2000, 18:137-148.
• [48]Harrison ML, Moore KA, Young MS, Flink D, Ochshorn E: Implementing the Comprehensive, Continuous, Integrated System of Care Model for Individuals with Co-Occuring Disorders: Preliminary Findings from a Residential Facility Serving Homeless Individuals. J Dual Diagn 2008, 4:238-259.
• [49]McHugo GJ, Drake RE, Teague GB, Xie H: Fidelity to Assertive Community Treatment and Client Outcomes in the New Hampshire Dual Disorders Study. Psychiatr Serv 1999, 50:818-824.
• [50]Wise EA: Evidence-Based Effectiveness of a Private Practice Intensive Outpatient Program With Dual Diagnosis Patients. J Dual Diagn 2010, 6:25-45.
• [51]Moore KA, Young MS, Barrett B, Ochshorn E: A 12-Month Follow-Up Evaluation of Integrated Treatment for Homeless Individuals With Co-Occurring Disorders. J Soc Serv Res 2009, 35:322-335.
• [52]Craig TKJ, Johnson S, McCrone P, Afuwape S, Hughes E, Gournay K, White I, Wanigaratne S, Leese M, Thornicroft G: Integrated Care for Co-occurring Disorders: Psychiatric Symptoms, Social Functioning, and Service Costs at 18 Months. Psychiatr Serv 2008, 59:276-282.
• [53]Magura S, Villano CL, Rosenblum A, Vogel HS, Betzler T: Consumer Evaluation of Dual Focus Mutual Aid. J Dual Diagn 2008, 4:170-185.
• [54]Pollack LE, Stuebben G, Sobhan T: Dually Diagnosed Inpatients' Satisfaction with Addiction Groups. J Psychosoc Nurs Ment Health Serv 1997, 35:18-23.
• [55]Attkisson CC, Zwick R: The client satisfaction questionnaire. Psychometric properties and correlations with service utilization and psychotherapy outcome. Eval Program Plann 1982, 5:233-237.
• [56]Fletcher TD, Cunningham JL, Calsyn RJ, Morse GA, Klinkenberg WD: Evaluation of Treatment Programs for Dual Disorder Individuals: Modeling Longitudinal and Mediation Effects. Adm Policy Ment Health Ment Health Serv Res 2008, 35:319-336.
• [57]Department of Health: Mental Health Policy Implementation Guide: Dual Diagnosis Good Practice Guide. London: Department of Health; 2002.
• [58]Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L: Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001, 52:469-476.
• [59]Gordon D, Burn D, Campbell A, Baker O: The 2007 user satisfaction survey of Tier 2 and 3 service users in England. London: National Treatment Agency; 2008.
• [60]Campbell A, Finch E, Brotchie J, Davis P: The International Treatment Effectiveness Project: Implementing psychosocial interventions for adult drug misusers. London: National Treatment Agency for Substance Misuse; 2007.
• [61]Ruggeri M, Lasalvia A, Salvi G, Cristofalo D, Bonetto C, Tansella M: Applications and usefulness of routine measurement of patients' satisfaction with community-based mental health care. Acta Psychiatr Scand 2007, 116:53-65.
• [62]Blenkiron P, Hammill CA: What determines patients' satisfaction with their mental health care and quality of life? Postgrad Med J 2003, 79:337-340.
• [63]Fontana A, Rosenheck R, Ruzek J, McFall M: Specificity of Patients' Satisfaction With the Delivery and Outcome of Treatment. JNMD 2006, 194:780-784.
• [64]Solomon P, Draine J: Satisfaction with Mental Health Treatment in a Randomized Trial of Consumer Case Management. JNMD 1994, 182:179-184.
• [65]Dearing RL, Barrick C, Dermen KH, Walitzer KS: Indicators of Client Engagement: Influences on Alcohol Treatment Satisfaction and Outcomes. Psychol Addict Behav 2005, 19:71-78.
• [66]De Wilde EF, Hendriks VM: The Client Satisfaction Questionnaire: Psychometric Properties in a Dutch Addict Population. Eur Addict Res 2005, 11:157-162.
• [67]Lehman AF: A quality of life interview for the chronically mentally ill. Eval Program Plann 1988, 11:51-62.
• [68]Xiao H, Barber JP: The Effect of Perceived Health Status on Patient Satisfaction. Value Health 2008, 11:719-725.
• [69]Graham J, Denoual I, Cairns D: Happy with your care? J Psychiatr Ment Health Nurs 2005, 12:173-178.
• [70]Conners NA, Franklin KK: Using focus groups to evaluate client satisfaction in an alcohol and drug treatment program. J Subst Abuse Treat 2000, 18:313-320.
• [71]Drake RE, Mueser KT: Psychosocial Approaches to Dual Diagnosis. Schizophr Bull 2000, 26:105-118.